Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review

다국어 초록 (Multilingual Abstract)

Objective: Electroconvulsive therapy (ECT) has proven to be effective in treatment-resistant depression (TRD). In recent reports,70% to 90% of patients with TRD responded to ECT. However, post-ECT relapse is a significant problem. There are no studies investigating risk factors associated with reintroducing ECT in depressive patients after remission previously achieved with former ECT. The aim of the present study is to examine such risk factors using a sample of TRD patients.
Methods: We conducted a chart review to examine patient outcomes and adverse events over short- and long-term periods.
Forty-two patients met the criteria for major depressive disorder.
Results: The response rate was 85.7% (36/42). There were no significant differences in the baseline characteristics of patients exhibiting remission, response or non-response. The rate of adverse events was 21.4% (9/42). Among 34 patients who were available for follow-up, 18 patients relapsed (relapse rate, 52.9%), and 6 patients were reintroduced to ECT. The patients’ age and age of onset were significantly higher in the re-ECT group than non re-ECT group.
Conclusion: Our results suggest that older age and older age of onset might be considered for requirement of re-ECT after remission previously achieved with former ECT.

참고문헌 (Reference)

1 Thase ME, "When at first you don't succeed: sequential strategies for antidepressant nonresponders" 58 (58): 23-29, 1997

2 Trivedi MH, "Treatment-resistant depression: new therapies on the horizon" 15 : 59-70, 2003

3 Kennedy SH, "Treatment resistant depression-- advances in somatic therapies" 19 : 279-287, 2007

4 O'Connor MK, "The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report" 9 : 382-390, 2001

5 Tokutsu Y, "The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy" 28 : 56-, 2012

6 Tominaga K, "Symptom predictors of response to electroconvulsive therapy in older patients with treatment-resistant depression" 4 : 515-519, 2011

7 Prudic J, "Resistance to antidepressant medications and short-term clinical response to ECT" 153 : 985-992, 1996

8 Tew JD Jr, "Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment" 19 : 1-4, 2007

9 Prudic J, "Medication resistance and clinical response to electroconvulsive therapy" 31 : 287-296, 1990

10 Russell JC, "Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome" 19 : 4-9, 2003

11 McDonald WM, "Is ECT cost-effective? A critique of the National Institute of Health and Clinical Excellence's report on the economic analysis of ECT" 22 : 25-29, 2006

12 Kikuchi A, "Identification of predictors of post-ictal delirium after electroconvulsive therapy" 63 : 180-185, 2009

13 Devanand DP, "Electroconvulsive therapy in the treatment-resistant patient" 14 : 905-923, 1991

14 Husain SS, "Electroconvulsive therapy in depressive illness that has not responded to drug treatment" 83 : 121-126, 2004

15 Gupta S, "Efficacy of maintenance electroconvulsive therapy in recurrent depression: a naturalistic study" 24 : 191-194, 2008

16 Gagné GG Jr, "Efficacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients" 157 : 1960-1965, 2000

17 Sackeim HA, "Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy" 328 : 839-846, 1993

18 Prudic J, "Effectiveness of electroconvulsive therapy in community settings" 55 : 301-312, 2004

19 Petrides G, "ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE" 17 : 244-253, 2001

20 Fink M, "Convulsive therapy: a review of the first 55 years" 63 : 1-15, 2001

21 Aronson TA, "Continuation therapy after ect for delusional depression: a naturalistic study of prophylactic treatments and relapse" 3 : 251-259, 1987

22 Sackeim HA, "Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial" 285 : 1299-1307, 2001

23 Knapp RG, "Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE)" 63 : 1337-1344, 2006

24 Frank E, "Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence" 48 : 851-855, 1991

25 Bailine SH, "Comparison of bifrontal and bitemporal ECT for major depression" 157 : 121-123, 2000

26 Kellner CH, "Combining ECT and antidepressants: time to reassess" 14 : 65-67, 1998

27 Greenhalgh J, "Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies" 9 : 1-156, 2005

28 Abrams R, "Antidepressant effects of right versus left unilateral ECT and the lateralization theory of ECT action" 146 : 1190-1192, 1989

29 Watts BV, "An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system" 27 : 105-108, 2011

30 Gardner BK, "A review of the cognitive effects of electroconvulsive therapy in older adults" 24 : 68-80, 2008

31 Hamilton M, "A rating scale for depression" 23 : 56-62, 1960

32 Sackeim HA, "A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities" 57 : 425-434, 2000